Treatment
HPV vaccine clinical trials
We’re tracking 64 recruiting studies that include HPV vaccine, each written for real people, not researchers, below.
Recruiting studies
- NCT06831929Recruiting
HPV vaccine encouragement for preteens
This study looks at ways to make it easier for preteens aged 10 to 12 to get the HPV vaccine, which protects against certain cancers. It aims to see if simple reminders or education can increase vaccination rates.
Sacramento, CaliforniaAges 10–12 - NCT07648953Recruiting
HPV Vaccine Education Videos for Cancer Survivors
This study tests short educational videos on Facebook to help young cancer survivors complete their HPV vaccine series. The HPV vaccine protects against certain cancers, and this trial aims to see if videos can help more survivors get vaccinated.
Salt Lake City, UtahAges 18–26 - NCT05208710RecruitingEarly Phase 1
Study new HPV vaccine in healthy adults
This early study tests a new HPV (human papillomavirus) vaccine to see if it can safely trigger an immune response in healthy adults. It’s for people who have not had an HPV vaccine before and can follow study vaccination and pregnancy-prevention rules.
HeidelbergAges 18–45 - NCT06995157Recruiting
HPV infections and vaccine attitudes in Slovenian women
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
Ljubljana, Municipality of DomžaleAges Up to 35 years - NCT07498075Recruiting
Digital messages to help Nigerian parents decide about HPV vaccine
This study tests digital messages (like texts or videos) to help parents in Nigeria decide about the HPV vaccine for their daughters. The vaccine protects against certain cancers, and the goal is to see what messages work best.
LagosAges 27 years+ - NCT07156084RecruitingPhase 4
HPV vaccine long-term effect study for young adults
This study checks if one dose of the 9-valent HPV vaccine given at ages 9-11 still protects you 6 years later. It is for people who only had that single dose and no other HPV shots.
Québec, QuebecAges 15–17 - NCT07377656RecruitingPhase 2
HPV vaccine delivery with childhood shots
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
AccraAges 9 months–20 years - NCT06227689Recruiting
Chatbot study for HPV vaccine awareness
This study tests whether a chatbot can help parents learn about the HPV vaccine and encourage them to get their daughters vaccinated. It is for parents of middle school girls who haven't yet gotten the HPV shot.
Chizhou, AnhuiAges 10–16 - NCT06397378Recruiting
Video to help college students learn about HPV vaccine
This study is testing a video to help college students learn about the HPV vaccine and consider getting it. You'll watch a short video and share your thoughts in a survey. It's a chance to learn more about a vaccine that can prevent certain cancers.
East Lansing, MichiganAges 18–26 - NCT06756269RecruitingPhase 2
HPV vaccine study for people aged 9 to 45
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
Nanning, GuangxiAges 9–45 - NCT06862102Recruiting
Multiple HPV Infections and Cervical Lesion Risk
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
Pavia, PaviaAges 18 years+ - NCT07301905Recruiting
HPV vaccine study for parents in Flint, MI
This study tests a culturally tailored health message to see if it helps parents feel more open to the HPV vaccine for their daughters. It focuses on families in Flint whose daughters have not yet received the vaccine.
Flint, MichiganAges 18 years+ - NCT07266857Recruiting
Study on HPV vaccine education in middle schools
This trial tests if an educational program called e-Bug can increase HPV vaccination rates. It uses only anonymous data from schools, so no individual enrollment is needed.
Nice, Alpes MaritimesAges Any age - NCT05334706RecruitingPhase 4
Vaccine study to lower HPV spread in HPV-positive women
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
L'Hospitalet de Llobregat, CataloniaAges 18 years+ - NCT05291845RecruitingPhase 2
Vaccine study for treating multiple common skin warts
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
Zagazig, Al SharqiaAges 9 years+ - NCT05371353Recruiting
Study of how long HPV vaccine immunity lasts
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
Yangchun, GuangdongAges 9–45 - NCT05672927RecruitingPhase 4
Comparing HPV vaccine schedules: 2 doses vs 3 doses
This study compares how well your immune system responds to an HPV vaccine given as either 2 doses or 3 doses in people ages 27–45 who have never had the HPV vaccine. It may help improve HPV prevention strategies and guide the best dose schedule for adults.
Galveston, TexasAges 27–45 - NCT04910802RecruitingPhase 4
HPV vaccine with routine HPV screening for ages 22–26
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
StockholmAges 22–27 - NCT05495906RecruitingPhase 4
Lower-dose HPV vaccine study for women with HIV
This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.
Surrey, British ColumbiaAges 18–45 - NCT06686043RecruitingPhase 2
HPV vaccine, imiquimod, and metformin for advanced cervical or vulvar cancer
This trial tests a combination of an HPV vaccine, an immune cream (imiquimod), and a diabetes drug (metformin) together with standard chemoradiation. The goal is to see if this mix helps treat advanced cervical, vaginal, or vulvar cancers better than standard care alone.
Houston, TexasAges 18–64 - NCT06380114Recruiting
Standing orders for HPV vaccine
This trial tests if having a 'standing order' (an automatic request) for the HPV vaccine helps more preteens get it. It's for clinics that don't already give HPV shots to most of their teenage patients and have enough 11- and 12-year-olds who still need the vaccine.
Rochester, New YorkAges 9–17 - NCT05984849Recruiting
A Game to Learn About the HPV Vaccine
This study uses a game to teach children ages 11-14 about the HPV vaccine and why it's important. It's for kids who haven't gotten the vaccine yet and their parent or guardian.
Chandler, ArizonaAges 11–14 - NCT06650956Recruiting
HPV vaccine and health education for teens in Laos
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
Muang Sing, ProvinceAges 10–13 - NCT06997705Recruiting
HPV vaccine and health check for teens in Ivory Coast
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
AbidjanAges 9–110
What HPV vaccine is being studied for
Conditions with recruiting HPV vaccine studies.
Common questions
- Are there clinical trials studying HPV vaccine?
- Yes. Clin2 currently lists 64 recruiting studies that include HPV vaccine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a HPV vaccine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is HPV vaccine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether HPV vaccine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.